Table 3.
Mortality and mitral valve reintervention at 3 years and long-term stratified mitral valve procedure
| Overall | SMVr | TEER | P value | |
|---|---|---|---|---|
| Death | ||||
| 3-y | 20.3% (91) | 10.4% (30) | 37.9% (61) | <.0001 |
| Long-term | 19.2% (127) | 12.0% (47) | 30.0% (80) | <.0001 |
| Average days of follow-up | 949.1 ± 641.9 (median, 842.5) | 1119.9 ± 682.2 (median, 1098) | 697.6 ± 473.8 (median, 660) | <.0001 |
| Average days to death | 636.1 ± 497.6 (median, 624) | 744.7 ± 596.1 (median, 659) | 572.2 ± 420.6 (median, 618.5) | .19 |
| Adjusted HR (95% CI), P value | 3-y: HR, 3.55 (2.33-5.43), P < .0001 | Long-term: HR, 2.74 (1.80-4.16), P < .0001 | ||
| Follow-up mitral valve intervention | ||||
| 3-y | 4.9% (22) | 2.4% (7) | 9.3% (15) | .002 |
| Long-term | 4.5% (30) | 2.5% (10) | 7.5% (20) | .003 |
| Average days to follow-up mitral intervention | 315.6 ± 473.6 (median, 145) | 600.1 ± 713.2 (median, 388.5) | 173.3 ± 193.8 (median, 119.5) | .04 |
| Adjusted HR (95% CI), P value | 3-y: HR, 5.08 (2.17-11.18), P < .0001 | Long-term: HR, 4.73 (2.08-10.74), P < .0001 | ||
Outcome frequencies are presented as % (n). A total of 449 patients had the opportunity for 3-years of follow-up (SMVr, n = 288; TEER, n = 161). SMVr, Surgical mitral valve repair; TEER, transcatheter edge-to-edge mitral valve repair; HR, hazard ratio; CI, confidence interval.